Veracyte, Inc. (VCYT) is a publicly traded Healthcare sector company. As of May 21, 2026, VCYT trades at $45.00 with a market cap of $3.31B and a P/E ratio of 40.34. VCYT moved +8.37% today. Year to date, VCYT is +3.58%; over the trailing twelve months it is +56.86%. Its 52-week range spans $22.61 to $50.71. Analyst consensus is buy with an average price target of $45.28. Rallies surfaces VCYT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded VCYT stock?
Recent politician trading activity in VCYT includes disclosures from Gilbert Cisneros and Gilbert Cisneros. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
VCYT Key Metrics
Key financial metrics for VCYT
Metric
Value
Price
$45.00
Market Cap
$3.31B
P/E Ratio
40.34
EPS
$1.11
Dividend Yield
0.00%
52-Week High
$50.71
52-Week Low
$22.61
Volume
111
Avg Volume
0
Revenue (TTM)
$541.74M
Net Income
$88.01M
Gross Margin
70.92%
Congressional Trades in VCYT
Gilbert Cisneros purchase VCYT on Feb 18, 2026 (amount: $15.00K).
Gilbert Cisneros purchase VCYT on Jun 16, 2025 (amount: $15.00K).
Recent politician trading activity in VCYT includes disclosures from Gilbert Cisneros and Gilbert Cisneros. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in VCYT?
Yes. Rallies tracks politician and congressional stock disclosures for VCYT, including reported purchases, sales, dates, owners, and trade amounts when available.
Is VCYT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VCYT. It does not provide personalized investment advice.
